Prof. Montclare obtained funding through the National Institute of Health (NIH) Countermeasures Against Chemical Threats (CounterACT) for the detoxification of neurotoxic chemical warfare agents such as VX. Prof. Montclare will be working aside Prof. Richard Bonnie, Director of the NYU Center for Data Science, and Dr. Tamara Otto at the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD), to design a phosphotriesterase (PTE) enzyme capable efficiently neutralizing VX. You can read more about the collaborative effort by clicking here.
October 12th, 2017
